Researcher

Xiao Yang

Center of Stomatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

JUL 29, 2026 · JOURNAL ARTICLE

Treatment effects on sphingosine-1-phosphate and its receptors in major depressive disorder: implications for biomarkers

BMC Psychiatry

A single-centre, uncontrolled observational study with modest sample size (n=56 MDD patients) showing biomarker changes in response to treatment and diagnostic discrimination, but lacking a randomized comparator arm and requiring external validation before clinical deployment.

PromisingFang Liu Tryptophan and Brain Disorders Anlong Jiang

Reported

Sample size (MDD patients)56

Sample size (healthy controls)42

Treatment duration8 weeks

JUN 4, 2026 · JOURNAL ARTICLE

Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology.

Cancer Biology & Therapy

This is a narrative review synthesizing existing knowledge on synthetic biology approaches to bacterial cancer immunotherapy, without reporting original experimental data, primary endpoints, or comparative efficacy claims.

Expert GuidanceXiao Yang Bacteria-based Immunotherapy Hejin Zhang

Study details

DesignNarrative review